Toronto Dominion Bank
COEPW

Toronto Dominion Bank’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Toronto Dominion Bank’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$537 Sell
44,737
-100
-0.2% -$1 ﹤0.01% 2036
2025
Q4 		$448 Hold
44,837
– – ﹤0.01% 1967
2025
Q3 		$1.17K Sell
44,837
-118
-0.3% -$3 ﹤0.01% 1835
2025
Q2 		$1.29K Buy
+44,955
New +$985 ﹤0.01% 1707

Other funds holding COEPW

RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HHGC
Hunting Hill Global Capital New York $129M AUM 17.34% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Toronto Dominion Bank's COEPW Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Coeptis Therapeutics Warrants (COEPW) stake by 0.22% in Q1 2026, selling an estimated $1 and leaving 44,737 shares worth $537. The position accounts for ﹤0.01% of the portfolio, ranked #2036.

Toronto Dominion Bank first reported a position in COEPW in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.29K in Q2 2025. 10 funds tracked by Wall St. Rank hold COEPW as of Q1 2026.

  • Toronto Dominion Bank held 44,737 shares of Coeptis Therapeutics Warrants worth $537 as of Q1 2026.
  • Toronto Dominion Bank sold 100 Coeptis Therapeutics Warrants shares in Q1 2026, an estimated $1.
  • Coeptis Therapeutics Warrants made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #2036 holding.
  • Toronto Dominion Bank first reported a position in Coeptis Therapeutics Warrants in Q2 2025 and has held it in 4 quarters since.
  • Toronto Dominion Bank's Coeptis Therapeutics Warrants position peaked at $1.29K in Q2 2025.
  • 10 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.